DR. LELAND GERSHELL, M.D., PH.D.
Osteopathic Medicine at 77 St, New York, NY

License number
New York 230701
Category
Osteopathic Medicine
Type
General Practice
Address
Address
201 E 77Th St APT 9F, New York, NY 10075
Phone
(212) 737-6154
National Provider ID: 1639493976
LicenseFiles verified this license of Nov 7, 2017 at the National Plan and Provider Enumeration System.

Organization information

See more information about LELAND GERSHELL at bizstanding.com

Leland Gershell MD,PHD

170 E 87 St Apt W15A, New York, NY 10128

Industry:
Family Doctor
Phone:
(212) 737-6154 (Phone)
Leland James Gershell

Professional information

Leland Gershell Photo 1

Leland Gershell
Position:
Chief Financial Officer at TONIX Pharmaceuticals
Location:
New York, New York
Industry:
Pharmaceuticals
Work:
TONIX Pharmaceuticals - New York, NY since Apr 2012 - Chief Financial Officer Madison Williams and Company May 2011 - Apr 2012 - Managing Director Apothecary Capital LLC Oct 2008 - Oct 2009 - Senior Analyst Cowen and Company Nov 2004 - Sep 2008 - Equity Analyst - Biotechnology
Education:
Columbia University College of Physicians and Surgeons 1994 - 2002
Columbia University in the City of New York 1996 - 2000
Dartmouth College 1990 - 1994
Stuyvesant High School 1986 - 1990
Collegiate School 1978 - 1986

Leland Gershell Photo 2

Dr. Leland Gershell, New York NY - MD (Doctor of Medicine)
Specialties:
Family Medicine
Address:
201 E 77Th St STE 9F, New York 10075
(212) 737-6154 (Phone)
Languages:
English
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1998

Leland Gershell Photo 3

Class Of Cytodifferentiating Agents And Histone Deacetylase Inhibitors, And Methods Of Use Thereof

US Patent:
6511990, Jan 28, 2003
Filed:
Aug 24, 2000
Appl. No.:
09/645430
Inventors:
Ronald Breslow - Englewood NJ
Sandro Belvedere - New York NY
Leland Gershell - New York NY
Thomas A. Miller - New York NY
Paul A. Marks - Washington CT
Victoria M. Richon - New York NY
Richard A. Rifkind - New York NY
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 314709
US Classification:
514314, 514249, 514261, 514266, 514307, 514309, 514311, 514316, 514318, 514354, 514355, 514575, 544277, 544258, 546171, 546141, 546146, 546314, 546316, 562623, 562622
Abstract:
The present invention provides the compound having the formula: wherein each of R and R is, substituted or unsubstituted, aryl, cycloalkyl, cycloalkylamino, naphtha, pyridineamino, piperidino, t-butyl, aryloxy, arylalkyloxy, or pyridine group; wherein A is an amido moiety, —O—, —S—, —NH—, or —CH —; and wherein n is an integer from 3 to 8. The present invention also provides a method of selectively inducing growth arrest, terminal differentiation and/or apoptosis of neoplastic cells and thereby inhibiting proliferation of such cells. Moreover, the present invention provides a method of treating a patient having a tumor characterized by proliferation of neoplastic cells. Lastly, the present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically acceptable amount of the compound above.

Leland Gershell Photo 4

Novel Class Of Cytodifferentiating Agents And Histone Deacetylase Inhibitors, And Methods Of Use Thereof

US Patent:
2007001, Jan 11, 2007
Filed:
Jun 22, 2006
Appl. No.:
11/474042
Inventors:
Ronald Breslow - Englewood NJ, US
Sandro Belvedere - New York NY, US
Leland Gershell - New York NY, US
Thomas Miller - New York NY, US
Paul Marks - Washington CT, US
Victoria Richon - New York NY, US
Richard Rifkind - New York NY, US
International Classification:
C07D 473/02, C07D 211/06, C07C 259/04, C07D 213/56
US Classification:
544277000, 546226000, 562621000, 562623000, 546336000, 548190000
Abstract:
The present invention provides the compound having the formula: wherein each of Rand Ris, substituted or unsubstituted, aryl, cycloalkyl, cycloalkylamino, naphtha, pyridineamino, piperidino, t-butyl, aryloxy, arylalkyloxy, or pyridine group; wherein A is an amido moiety, —O—, —S—, —NH—, or —CH—; and wherein n is an integer from 3 to 8. The present invention also provides a method of selectively inducing growth arrest, terminal differentiation and/or apoptosis of neoplastic cells and thereby inhibiting proliferation of such cells. Moreover, the present invention provides a method of treating a patient having a tumor characterized by proliferation of neoplastic cells. Lastly, the present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically acceptable amount of the compound above.

Leland Gershell Photo 5

Novel Class Of Cytodifferentiating Agents And Histone Deacetylase Inhibitors, And Methods Of Use Thereof

US Patent:
2007001, Jan 11, 2007
Filed:
Jun 22, 2006
Appl. No.:
11/473839
Inventors:
Ronald Breslow - Englewood NJ, US
Sandro Belvedere - New York NY, US
Leland Gershell - New York NY, US
Thomas Miller - New York NY, US
Paul Marks - Washington CT, US
Victoria Richon - New York NY, US
Richard Rifkind - New York NY, US
International Classification:
A61K 31/52, A61K 31/445, A61K 31/44, C07C 259/04
US Classification:
514263400, 514317000, 514370000, 514357000, 514575000, 544277000, 546226000, 546304000, 562621000, 562623000
Abstract:
The present invention provides the compound having the formula: wherein each of Rand Ris, substituted or unsubstituted, aryl, cycloalkyl, cycloalkylamino, naphtha, pyridineamino, piperidino, t-butyl, aryloxy, arylalkyloxy, or pyridine group; wherein A is an amido moiety, —O—, —S—, —NH—, or —CH—; and wherein n is an integer from 3 to 8. The present invention also provides a method of selectively inducing growth arrest, terminal differentiation and/or apoptosis of neoplastic cells and thereby inhibiting proliferation of such cells. Moreover, the present invention provides a method of treating a patient having a tumor characterized by proliferation of neoplastic cells. Lastly, the present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically acceptable amount of the compound above.

Leland Gershell Photo 6

Cytodifferentiating Agents And Histone Deacetylase Inhibitors, And Methods Of Use Thereof

US Patent:
7345174, Mar 18, 2008
Filed:
Jun 22, 2006
Appl. No.:
11/474043
Inventors:
Ronald Breslow - Englewood NJ, US
Sandro Belvedere - New York NY, US
Leland Gershell - New York NY, US
Thomas A. Miller - New York NY, US
Paul A. Marks - Washington CT, US
Victoria M. Richon - New York NY, US
Richard A. Rifkind - New York NY, US
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C07D 221/02, C07D 211/00, C07D 211/60, C07C 233/60, A61K 31/02, A61K 31/12, A61K 31/22
US Classification:
546112, 546184, 546192, 546245, 546 90, 564123, 514183, 514506, 514675, 514759, 544 56, 544256
Abstract:
The present invention provides the compound having the formula:.

Leland Gershell Photo 7

Class Of Cytodifferentiating Agents And Histone Deacetylase Inhibitors, And Methods Of Use Thereof

US Patent:
7126001, Oct 24, 2006
Filed:
Oct 25, 2002
Appl. No.:
10/281875
Inventors:
Ronald Breslow - Englewood NJ, US
Sandro Belvedere - New York NY, US
Leland Gershell - New York NY, US
Thomas A. Miller - New York NY, US
Paul A. Marks - Washington CT, US
Victoria M. Richon - New York NY, US
Richard A. Rifkind - New York NY, US
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C07D 215/38, C07D 473/02, C07C 259/04, A61K 31/47
US Classification:
546171, 546141, 546146, 546314, 546315, 544277, 544258, 562622, 562623, 514314, 514249, 514261, 514268, 514307
Abstract:
The present invention provides the compound having the formula:.

Osteopathic Medicine licenses in New York










Other Doctors licenses in New York